ArticleJournal of hepatocellular carcinoma2024

Clinical Therapy: HAIC Combined with Tyrosine Kinase Inhibitors and Programmed Cell Death Protein-1 Inhibitors versus HAIC Alone for Unresectable Hepatocellular Carcinoma.

Baokun Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.